Search Within

Martin Stuart Tallman

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (57)
  2. Journal Article (52)
  3. Research Letter (3)
  4. Correspondence (1)
Groups
  1. Adult Leukemia (113)
  2. Center for Hematologic Malignancies (113)
  3. Department of Medicine (113)
  4. Epidemiology and Biostatistics (113)
  5. Hematologic Malignancies, Division of (113)
  6. Biostatistics Service (105)

More Groups

People
  1. Sean Devlin (65)
  2. Ross Levine (55)
  3. Eytan Stein (39)
  4. Christopher Famulare (26)
  5. Jae Park (26)
  6. Aaron Goldberg (24)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (9)
  6. 2020 (12)

More Years

Publications
  1. Blood (52)
  2. Leukemia Research (11)
  3. Haematologica (7)
  4. American Journal of Hematology (4)
  5. Biology of Blood and Marrow Transplantation (4)
  6. Blood Advances (4)

More Publications

Publishers
  1. American Society of Hematology (56)
  2. Elsevier Ltd (11)
  3. Nature Publishing Group (8)
  4. Ferrata Storti Foundation (7)
  5. Elsevier Inc. (6)
  6. American Association for Cancer Research (4)

More Publishers

Results (113)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Molecular and cytogenetic characteristics of myeloid malignancies following luminal gastrointestinal cancer
    Journal Article

    Epstein-Peterson, Z. D.; Devlin, S. M.; Stein, E. M.; Klimek, V. M.; Saltz, L. B.; Tallman, M. S.
    Leukemia Research (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • TP53 mutations predict poorer responses to CPX-351 in acute myeloid leukemia
    Meeting Abstract

    Goldberg, A. D.; Talati, C.; Desai, P.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Sallman, D. A.; Lancet, J. E.; Roboz, G. J.; Sweet, K. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Molecular predictors and current management of minimal residual disease (MRD) following induction chemotherapy for acute myeloid leukemia (AML)
    Meeting Abstract

    Goldberg, A. D.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Menghrajani, K.; Patel, M.; Cai, S.; Dunbar, A.; Epstein-Peterson, Z. D.; McGovern, E.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
    Journal Article

    Intlekofer, A. M.; Shih, A. H.; Wang, B.; Nazir, A.; Rustenburg, A. S.; Albanese, S. K.; Patel, M.; Famulare, C.; Correa, F. M.; Takemoto, N.; more...
    Nature (2018)

    Fulltext@MSK | Save
  • MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia
    Journal Article

    Brown, F. C.; Still, E.; Koche, R. P.; Yim, C. Y.; Takao, S.; Cifani, P.; Reed, C.; Gunasekera, S.; Ficarro, S. B.; Romanienko, P.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save